Vagal afferent neurons as targets for treatment

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01)

Patent

CA 2597030

A method of identifying a compound capable of reducing or preventing prolonged sensory neuron hyper-excitability comprising the steps of: (a) administering the compound to an experimental non-human animal having prolonged sensory neuron hyper-excitability; (b) generating an expression profile of the genes modulated in the Nodose Ganglia (NG) of the animal of step (a); (c) comparing the expression profile obtained in (b) with the expression profile of a corresponding panel of genes expressed in the NG of an experimental non-human animal having no prolonged sensory neuron hyper-excitability; wherein a positive correlation of the expression profiles is indicative that the compound is capable of reducing or preventing prolonged sensory neuron hyper- excitability in NG.

L'invention concerne une méthode d'identification d'un composé permettant de réduire ou de prévenir une hyperexcitabilité neuronale sensorielle prolongée. Cette méthode comprend les étapes consistant à: (a) administrer le composé à un animal non humaind' expérimentation présentant une hyperexcitabilité neuronales sensorielle prolongée; (b) générer un profil d'expression des gènes modulés dans le ganglion noueux (NG) de l'animal de l'étape (a); (c) comparer le profil d'expression obtenu à l'étape (b) avec le profil d'expression d'un panel correspondant de gènes exprimés dans le NG d'un animal non humain d'expérimentation présentant une hyperexcitabilité neuronale sensorielle prolongée. Une corrélation positive des profils d'expression indique que le composé peut réduire ou prévenir l'hyperexcitabilité neuronale sensorielle prolongée dans le NG.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Vagal afferent neurons as targets for treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vagal afferent neurons as targets for treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vagal afferent neurons as targets for treatment will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1742809

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.